Implementation of an Opioid Weaning Protocol at a Tertiary Care Children's Hospital

Jenna Ford1, Aaron Harthan1, Jeremy McGarvey1

  • 1OSF HealthCare Children's Hospital of Illinois, Peoria, Illinois.

Hospital Pediatrics
|October 4, 2022
PubMed

Insights

Implementing a pharmacist-led opioid weaning protocol and the Withdrawal Assessment Tool-1 significantly reduced opioid wean duration and hospital stays in pediatric patients. This approach offers a standardized method for managing opioid withdrawal in children.

Area of Science:

  • Pediatric critical care medicine
  • Pharmacology
  • Clinical pharmacy

Background:

  • Opioid weaning in pediatric patients can be prolonged and complex.
  • Standardized protocols are needed to manage opioid withdrawal effectively.
  • Pharmacist involvement can optimize medication management.

Purpose of the Study:

  • To evaluate a pharmacist-managed opioid weaning regimen combined with an objective opioid withdrawal assessment tool.
  • To determine the impact on opioid wean duration, length of hospital stay, and withdrawal episodes.
  • To assess the feasibility of implementing this combined approach in pediatric care.

Main Methods:

  • Retrospective cohort study of 115 pediatric inpatients from 2012-2020.
  • Phased implementation: baseline, pharmacist-led weaning, and addition of the Withdrawal Assessment Tool-1 (WAT-1).
  • Data collected on wean duration, hospital length of stay, and opioid withdrawal episodes requiring rescue doses.

Main Results:

  • Significant reductions in total wean duration and hospital length of stay were observed from baseline to the intervention phase with WAT-1.
  • Episodes of opioid withdrawal requiring rescue medication also decreased significantly.
  • No significant differences in patient characteristics were noted between study phases.

Conclusions:

  • A pharmacist-managed opioid weaning regimen, enhanced by the WAT-1, significantly shortens opioid wean duration and hospital length of stay in pediatric patients.
  • This combined strategy demonstrates potential for widespread adoption and standardization in tertiary care children's hospitals.
  • Optimizing opioid withdrawal management can improve patient outcomes and resource utilization.
Abstract

Related Concept Videos

Opioid Analgesics: Synthetic and Semisynthetic Opioids01:15

Opioid Analgesics: Synthetic and Semisynthetic Opioids

Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
392
Analgesia and Pain Management01:25

Analgesia and Pain Management

Pain is critical to various clinical pathologies, provoking an urgent need for effective management. Pain, whether acute or chronic, is a complex neurochemical process. Its alleviation depends on the type, with nonopioid analgesics effective for mild to moderate pain, such as musculoskeletal or inflammatory pain, while neuropathic pain responds best to anticonvulsants, tricyclic antidepressants, or serotonin/norepinephrine reuptake inhibitors. For severe acute or chronic pain, opioids may be...
763
Opioid Receptors: Overview01:22

Opioid Receptors: Overview

Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2,...
1.5K
Opioid Analgesics: Morphine and Other Natural Cogeners01:20

Opioid Analgesics: Morphine and Other Natural Cogeners

Opioids are a class of drugs that mimic endogenous opioid peptides and act on opioid receptors, and help in pain relief. These compounds are classified as natural, synthetic, or semi-synthetic. Natural opioids, like morphine, codeine, and thebaine, are derived from the opium poppy plant (Papaver somniferum or Papaver album) and are termed opiates. Synthetic opioids are artificial, while semi-synthetic opioids combine natural and synthetic compounds. Morphine, a prototypical opioid, possesses a...
340
Kidney Transplant III: Nursing Management01:16

Kidney Transplant III: Nursing Management

Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
71
Chronic Kidney Disease III: Interprofessional Care01:28

Chronic Kidney Disease III: Interprofessional Care

Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...
71